Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1986-01

AUTHORS

Y. Ambroes, I. Ronflette, L. Dodion

ABSTRACT

Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS) More... »

PAGES

1-7

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00541460

DOI

http://dx.doi.org/10.1007/bf00541460

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1003363483

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3780835


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diuretics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lipids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnesium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Potassium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Torsemide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Uric Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Saint Etienne Clinic, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ambroes", 
        "givenName": "Y.", 
        "id": "sg:person.01242546465.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242546465.34"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Saint Etienne Clinic, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ronflette", 
        "givenName": "I.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Medical Department A. Christiaens S.A., Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dodion", 
        "givenName": "L.", 
        "id": "sg:person.01356775065.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356775065.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01747104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002452921", 
          "https://doi.org/10.1007/bf01747104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01747104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002452921", 
          "https://doi.org/10.1007/bf01747104"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0026-0495(73)90264-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008746933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197104152841506", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010957021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0002-9149(79)80338-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011589858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0021-9150(80)90204-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013813794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00541465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022122500", 
          "https://doi.org/10.1007/bf00541465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00541465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022122500", 
          "https://doi.org/10.1007/bf00541465"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00625798", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029985014", 
          "https://doi.org/10.1007/bf00625798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.3.5827.620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031136057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2125.1978.tb00837.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038315847"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(82)91506-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038590926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.1980.03310150027023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044819086"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.280.6218.905", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048678221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9343(69)90187-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050813268"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.244.15.1691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054139508"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0028-1111261", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057126788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0028-1113442", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057128956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078454423", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082160355", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1986-01", 
    "datePublishedReg": "1986-01-01", 
    "description": "Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS)", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00541460", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects", 
    "pagination": "1-7", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1005a457b0f6b06a30eec6f67b2384f7351ab6df5091873f83037b63fc8b144c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3780835"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "1256165"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00541460"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1003363483"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00541460", 
      "https://app.dimensions.ai/details/publication/pub.1003363483"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130830_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00541460"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00541460'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      64 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00541460 schema:about N0cfc6cee089f4a40b6d85ac561e4c184
2 N0f7a3b27aaea4c01b129119affff9e9b
3 N1da9e8db61a240bcbeb9d08cb8453e99
4 N24e8759ad4004736a4b6391d9f296a2c
5 N384bd5ecb15f40d19e738db116d3f8b1
6 N3bf56a64291e4fbc8122a1fd804f4498
7 N52fdf638f470487297cfc83233402535
8 N53b135420a8148929f07ce01a834ef15
9 N5db2757f60224860a88189172b4c8db5
10 N74800e7cfae74f679639fcb9ae526fa6
11 N7c7bff8b273242b3acb303b07a983783
12 N80c828eaed7240d3913afc19467913fc
13 Nbd8aa0ec67a24ce390d4b1ca919126de
14 Nc4546c9bcd5e43758547f6d4991bd150
15 Nd0194685e768462bbe4c189440c9910f
16 Nde042988aa744ca5a0ac3637725e372f
17 Nf0baffd352244b78aab8571e6cc1b704
18 anzsrc-for:11
19 anzsrc-for:1116
20 schema:author N9ebbb147e630410c84d7a72a06070097
21 schema:citation sg:pub.10.1007/bf00541465
22 sg:pub.10.1007/bf00625798
23 sg:pub.10.1007/bf01747104
24 https://app.dimensions.ai/details/publication/pub.1078454423
25 https://app.dimensions.ai/details/publication/pub.1082160355
26 https://doi.org/10.1001/jama.1980.03310150027023
27 https://doi.org/10.1001/jama.244.15.1691
28 https://doi.org/10.1016/0002-9343(69)90187-9
29 https://doi.org/10.1016/0021-9150(80)90204-x
30 https://doi.org/10.1016/0026-0495(73)90264-3
31 https://doi.org/10.1016/s0002-9149(79)80338-0
32 https://doi.org/10.1016/s0140-6736(82)91506-9
33 https://doi.org/10.1055/s-0028-1111261
34 https://doi.org/10.1055/s-0028-1113442
35 https://doi.org/10.1056/nejm197104152841506
36 https://doi.org/10.1111/j.1365-2125.1978.tb00837.x
37 https://doi.org/10.1136/bmj.280.6218.905
38 https://doi.org/10.1136/bmj.3.5827.620
39 schema:datePublished 1986-01
40 schema:datePublishedReg 1986-01-01
41 schema:description Torasemide 40 mg/day p.o. was administered for 21 days to 8 healthy volunteers to investigate its pharmacodynamics, pharmacokinetics and safety on chronic administration. It induced a highly significant initial increase in 24-h urinary volume and 24-h excretion of sodium and chloride, but its affect diminished after the first days. On Days 0, 1, 10 and 21 the experiment was divided in 3 clearance phases, extending from 0 to 2 h, 2 to 6 h and 6 to 24 h after dosing. The fractional excretion of sodium, chloride, potassium, calcium, magnesium and inorganic phosphates peaked during the first 2 h and returned almost to the control value during the following two clearance phases. The phase-dependent changes were significant for all electrolytes, except for potassium and inorganic phosphate. Plasma electrolyte levels remained constant throughout the study, except for a small decrease in chloride and potassium and for an increase in calcium and magnesium. Fasting blood glucose and glucose tolerance test were unaffected. A small but significant decrease in LDL-cholesterol was observed on Day 10. Other plasma lipid components showed minor changes. Plasma uric acid levels were moderately increased. There was no significant change of the creatinine clearance. Body weight fell significantly (by about 2 kg) during the study. Tonal audiometry was normal before and after the study. There was no significant difference between the plasma levels of torasemide on Days 1, 10 and 21, nor between its elimination half-life on Days 1 and 21. Side-effects consisted mainly of fatigue and low-back pain on days of intense diuresis.(ABSTRACT TRUNCATED AT 250 WORDS)
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree false
45 schema:isPartOf N1f8ae3927a1f4473a6148c91a7c5c3ce
46 N776254d317a542e1a585ab0b60d8133e
47 sg:journal.1054337
48 schema:name Diuretic activity, safety and pharmacokinetics of torasemide during chronic treatment in normal subjects
49 schema:pagination 1-7
50 schema:productId N2161414f584a44d4a71750ecd676d2a6
51 N7becad1722754edfb4595e8b6d46453f
52 N81971d06b1e24e89b13716759f919e5e
53 N9331d1ca9e7f443ab348a405300ad7db
54 Nb8d05d2de5f2459fae26480e7b24d7c1
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003363483
56 https://doi.org/10.1007/bf00541460
57 schema:sdDatePublished 2019-04-11T14:01
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N9015959fbd074e5397bb966b6ccc52f1
60 schema:url http://link.springer.com/10.1007/BF00541460
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N0cfc6cee089f4a40b6d85ac561e4c184 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Sodium
66 rdf:type schema:DefinedTerm
67 N0f7a3b27aaea4c01b129119affff9e9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Kinetics
69 rdf:type schema:DefinedTerm
70 N1da9e8db61a240bcbeb9d08cb8453e99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Torsemide
72 rdf:type schema:DefinedTerm
73 N1f8ae3927a1f4473a6148c91a7c5c3ce schema:issueNumber Suppl 1
74 rdf:type schema:PublicationIssue
75 N2161414f584a44d4a71750ecd676d2a6 schema:name pubmed_id
76 schema:value 3780835
77 rdf:type schema:PropertyValue
78 N24e8759ad4004736a4b6391d9f296a2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Potassium
80 rdf:type schema:DefinedTerm
81 N384bd5ecb15f40d19e738db116d3f8b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Calcium
83 rdf:type schema:DefinedTerm
84 N3bf56a64291e4fbc8122a1fd804f4498 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Sulfonamides
86 rdf:type schema:DefinedTerm
87 N52fdf638f470487297cfc83233402535 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Blood Glucose
89 rdf:type schema:DefinedTerm
90 N53b135420a8148929f07ce01a834ef15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Female
92 rdf:type schema:DefinedTerm
93 N5db2757f60224860a88189172b4c8db5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Urine
95 rdf:type schema:DefinedTerm
96 N6d8c1d26490646e9b9f6f7ea675a924d schema:affiliation N9d5d3a200b0e4a0d86ebb3e4d7db5175
97 schema:familyName Ronflette
98 schema:givenName I.
99 rdf:type schema:Person
100 N74800e7cfae74f679639fcb9ae526fa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Lipids
102 rdf:type schema:DefinedTerm
103 N74ae83b70ecf424aa5d34c41f55c056d schema:name Saint Etienne Clinic, Brussels, Belgium
104 rdf:type schema:Organization
105 N776254d317a542e1a585ab0b60d8133e schema:volumeNumber 31
106 rdf:type schema:PublicationVolume
107 N7becad1722754edfb4595e8b6d46453f schema:name doi
108 schema:value 10.1007/bf00541460
109 rdf:type schema:PropertyValue
110 N7c7bff8b273242b3acb303b07a983783 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Magnesium
112 rdf:type schema:DefinedTerm
113 N80c828eaed7240d3913afc19467913fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Adult
115 rdf:type schema:DefinedTerm
116 N81971d06b1e24e89b13716759f919e5e schema:name dimensions_id
117 schema:value pub.1003363483
118 rdf:type schema:PropertyValue
119 N9015959fbd074e5397bb966b6ccc52f1 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 N9331d1ca9e7f443ab348a405300ad7db schema:name nlm_unique_id
122 schema:value 1256165
123 rdf:type schema:PropertyValue
124 N9d5d3a200b0e4a0d86ebb3e4d7db5175 schema:name Saint Etienne Clinic, Brussels, Belgium
125 rdf:type schema:Organization
126 N9ebbb147e630410c84d7a72a06070097 rdf:first sg:person.01242546465.34
127 rdf:rest Naf87157ef6454679b266253641cc6064
128 Naf87157ef6454679b266253641cc6064 rdf:first N6d8c1d26490646e9b9f6f7ea675a924d
129 rdf:rest Ndff78ed4fdb8482ba203cd0b7016b933
130 Nb8d05d2de5f2459fae26480e7b24d7c1 schema:name readcube_id
131 schema:value 1005a457b0f6b06a30eec6f67b2384f7351ab6df5091873f83037b63fc8b144c
132 rdf:type schema:PropertyValue
133 Nb9f277c69c374ac8a39fa6c55bd272dc schema:name Medical Department A. Christiaens S.A., Brussels, Belgium
134 rdf:type schema:Organization
135 Nbd8aa0ec67a24ce390d4b1ca919126de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Humans
137 rdf:type schema:DefinedTerm
138 Nc4546c9bcd5e43758547f6d4991bd150 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Time Factors
140 rdf:type schema:DefinedTerm
141 Nd0194685e768462bbe4c189440c9910f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Male
143 rdf:type schema:DefinedTerm
144 Nde042988aa744ca5a0ac3637725e372f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Diuretics
146 rdf:type schema:DefinedTerm
147 Ndff78ed4fdb8482ba203cd0b7016b933 rdf:first sg:person.01356775065.07
148 rdf:rest rdf:nil
149 Nf0baffd352244b78aab8571e6cc1b704 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Uric Acid
151 rdf:type schema:DefinedTerm
152 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
153 schema:name Medical and Health Sciences
154 rdf:type schema:DefinedTerm
155 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical Physiology
157 rdf:type schema:DefinedTerm
158 sg:journal.1054337 schema:issn 0031-6970
159 1432-1041
160 schema:name European Journal of Clinical Pharmacology
161 rdf:type schema:Periodical
162 sg:person.01242546465.34 schema:affiliation N74ae83b70ecf424aa5d34c41f55c056d
163 schema:familyName Ambroes
164 schema:givenName Y.
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242546465.34
166 rdf:type schema:Person
167 sg:person.01356775065.07 schema:affiliation Nb9f277c69c374ac8a39fa6c55bd272dc
168 schema:familyName Dodion
169 schema:givenName L.
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356775065.07
171 rdf:type schema:Person
172 sg:pub.10.1007/bf00541465 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022122500
173 https://doi.org/10.1007/bf00541465
174 rdf:type schema:CreativeWork
175 sg:pub.10.1007/bf00625798 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029985014
176 https://doi.org/10.1007/bf00625798
177 rdf:type schema:CreativeWork
178 sg:pub.10.1007/bf01747104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002452921
179 https://doi.org/10.1007/bf01747104
180 rdf:type schema:CreativeWork
181 https://app.dimensions.ai/details/publication/pub.1078454423 schema:CreativeWork
182 https://app.dimensions.ai/details/publication/pub.1082160355 schema:CreativeWork
183 https://doi.org/10.1001/jama.1980.03310150027023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044819086
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1001/jama.244.15.1691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054139508
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/0002-9343(69)90187-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050813268
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/0021-9150(80)90204-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1013813794
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/0026-0495(73)90264-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008746933
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s0002-9149(79)80338-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011589858
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/s0140-6736(82)91506-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038590926
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1055/s-0028-1111261 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057126788
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1055/s-0028-1113442 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057128956
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1056/nejm197104152841506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010957021
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1111/j.1365-2125.1978.tb00837.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038315847
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1136/bmj.280.6218.905 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048678221
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1136/bmj.3.5827.620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031136057
208 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...